Ibrahim et al. [27] reported using spray-drying for basic fibroblast growth factor (bFGF) as alternative asthma and chronic obstructive pulmonary disease (COPD) therapies. The gene discussed is FGF2; the disease is chronic obstructive pulmonary disease.